Mkts

Haemonetics Corporation

NYSE: HAE
$120.92-0.42 (-0.35%)
As of Nov 17, 4:00 PM ET

Key statistics

Day range
119.98122.18
52-week range
51.00132.00
Today
Open120.68
Previous close120.92
Volume—
Valuation
Market cap5.51B
P/E ratio53.01×
EPS (TTM)2.24
Income & risk
Dividend / yield—
Beta0.60
Avg volume714.4K
Discussion

HAE News

Stories mentioning HAE from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 28Q4 '25Dec 27Q3 '25Sep 27Q2 '25Jun 28Q1 '25Mar 29Q4 '24Dec 28Q3 '24Sep 28Q2 '24Jun 29
Income Statement
Revenue346,351338,967327,315321,394330,599348,542345,511336,172
Cost of Goods Sold148,139136,581132,571129,150137,549154,995158,074161,248
Gross Profit198,212202,386194,744192,244193,050193,547187,437174,924
Operating Expenses
Research & Development14,44614,18714,87216,26118,30515,82914,13914,449
Sales General & Admin120,933109,154101,615110,719115,136106,459106,946108,248
Total Operating Expenses221,237134,990136,253138,372121,715134,518135,740135,168
Operating Income (Loss)(23,025)67,39658,49153,87271,33559,02951,69739,756
Interest Income
Interest Expense
Other Expense(5,374)(7,421)(7,206)(8,703)(598.00)(9,112)(6,993)6,957
Pretax Income(28,399)59,97551,28545,16970,73749,91744,70446,713
Tax Provision(8,252)15,23512,60111,13812,75612,42310,8738,340
Net Income (Loss)(20,147)44,74038,68434,03157,98137,49433,83138,373
Earnings Per Share (Basic)(0.43)0.960.810.711.150.750.660.75
Earnings Per Share (Diluted)(0.43)0.950.810.701.140.740.660.74
Weighted Average Shares Outstanding (Basic)47,17946,79247,59048,11150,33050,28650,89850,943
Weighted Average Shares Outstanding (Diluted)47,35446,98747,66448,35350,73050,63951,24051,564

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About HAE

Haemonetics Corporation (NYSE: HAE) is a stock listed on the New York Stock Exchange under the ticker symbol HAE. It last traded at $120.92 (Nov 17, 2026, 4:00 PM ET), down 0.3% on the day. That gives Haemonetics a market capitalisation of $5.5B and a price-to-earnings ratio of 53.0.

Over the past 52 weeks HAE has traded between $51.00 and $132.00.

Revenue for the quarter ended Mar 28, 2026 was $346.4M; a net loss of $20.1M. Revenue was up 4.8% from $330.6M in the quarter ended Mar 29, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 28, 2026$346.4M-$20.1M-5.8%
Dec 27, 2025$339.0M$44.7M13.2%
Sep 27, 2025$327.3M$38.7M11.8%
Jun 28, 2025$321.4M$34.0M10.6%

From Haemonetics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…